{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:38:00Z","timestamp":1792611480495,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15217-2","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T03:35:17Z","timestamp":1764214517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trend analysis of cancer mortality and years of life lost in the South of Iran 2004\u20132019. Joinpoint regression analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Habibollah","family":"Azarbakhsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Parsa","family":"Dehghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafar","family":"Hassanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Mirahmadizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"15217_CR1","doi-asserted-by":"crossref","unstructured":"Qiu H, Cao S, Xu RJC. Cancer incidence, mortality, and burden in china: a time-trend analysis and comparison with the united States and united Kingdom based on the global epidemiological data released in 2020. 2021;41(10):1037\u201348.","DOI":"10.1002\/cac2.12197"},{"key":"15217_CR2","doi-asserted-by":"crossref","unstructured":"Greenberg D, Earle C, Fang C-H, Eldar-Lissai A, Neumann PJJJNCI. When is cancer care cost-effective? A systematic overview of cost\u2013utility analyses in oncology. 2010;102(2):82\u20138.","DOI":"10.1093\/jnci\/djp472"},{"issue":"5","key":"15217_CR3","first-page":"926","volume":"27","author":"D Hashim","year":"2016","unstructured":"Hashim D, Boffetta P, La Vecchia C, Rota M, Bertuccio P, Malvezzi M, et al. Global Decrease Cancer Mortality: Trends Disparities. 2016;27(5):926\u201333.","journal-title":"Global Decrease Cancer Mortality: Trends Disparities"},{"issue":"125","key":"15217_CR4","first-page":"2","volume":"3","author":"P Andrade","year":"2017","unstructured":"Andrade P, Sacristan J, Dilla TJHEOROA. The economic burden of cancer in spain: a literature review. 2017;3(125):2.","journal-title":"\u00a0a literature review"},{"key":"15217_CR5","doi-asserted-by":"crossref","unstructured":"Li N, Wu P, Shen Y, Yang C, Zhang L, Chen Y et al. Predictions of mortality related to four major cancers in China, 2020 to 2030. 2021;41(5):404\u201313.","DOI":"10.1002\/cac2.12143"},{"issue":"7","key":"15217_CR6","first-page":"e2118457","volume":"4","author":"MC Wong","year":"2021","unstructured":"Wong MC, Huang J, Chan PS, Choi P, Lao XQ, Chan SM, et al. Global incidence and mortality of gastric cancer, 1980\u20132018. Global incidence and mortality of gastric cancer. 2021;4(7):e2118457-e.","journal-title":"Global incidence and mortality of gastric cancer"},{"key":"15217_CR7","unstructured":"oncology GBoDCCJJ. Global, regional, and National cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. 2019."},{"key":"15217_CR8","doi-asserted-by":"crossref","unstructured":"Akbari A, Khayamzadeh M, Salmanian R, Motlagh AG, Roshandel G, Nouri M et al. National cancer mortality-to-incidence ratio (MIR) in Iran (2005\u20132014). International Journal Cancer Manag. 2019;12(6).","DOI":"10.5812\/ijcm.94145"},{"key":"15217_CR9","unstructured":"Almasi Z, Mohammadian-Hafshejani A, Salehiniya HJJb. Incidence, mortality, and epidemiological aspects of cancers in Iran; differences with the world data. 2016;21(4):994\u20131004."},{"issue":"3","key":"15217_CR10","first-page":"309","volume":"47","author":"B Farhood","year":"2018","unstructured":"Farhood B, Geraily G, Alizadeh AJI. Incidence and mortality of various cancers in Iran and compare to other countries: a review article. a review article. 2018;47(3):309.","journal-title":"a review article"},{"key":"15217_CR11","doi-asserted-by":"crossref","unstructured":"Rezapour A, Nargesi S, Mezginejad F, Kemmak AR, Bagherzadeh RJIJPH. The economic burden of cancer in Iran during 1995\u20132019: a systematic review. Iran J Public Health. 2021;50(1):35.","DOI":"10.18502\/ijph.v50i1.5070"},{"key":"15217_CR12","doi-asserted-by":"crossref","unstructured":"Rezaianzadeh A, Ghoddusi Johari M, Niazkar HR, Khosravizadegan Z, Monabati A, Shiraziyeganeh BJHSR. Cancer incidence in Southern Iran, 2015\u2009\u2013\u20092018: A population based study on cancer registry profile of Fars Province. Health Sci Rep. 2023;6(6):e1333.","DOI":"10.1002\/hsr2.1333"},{"key":"15217_CR13","doi-asserted-by":"crossref","unstructured":"Brustugun OT, M\u00f8ller B, Helland \u00c5JBjoc. Years of life lost as a measure of cancer burden on a National level. Br J Cancer. 2014;111(5):1014\u201320.","DOI":"10.1038\/bjc.2014.364"},{"issue":"4","key":"15217_CR14","first-page":"225","volume":"13","author":"H Azarbakhsh","year":"2024","unstructured":"Azarbakhsh H, Jafari F, Jaafari Z, Dehghani SP, Shoaahaghighi P, Mirahmadizadeh AJJOH, et al. The trend of years of life lost caused by 4 main Non-Communicable diseases in Fars Province in the age group of 30\u201370 years. Joinpoint Regres Anal. 2024;13(4):225\u201332.","journal-title":"Joinpoint Regres Anal"},{"issue":"3","key":"15217_CR15","first-page":"667","volume":"23","author":"M Etemadi","year":"2025","unstructured":"Etemadi M, Mousavi SN, Najafi BJCJES. Factors affecting climate-smart agriculture development in Fars Province. Iran. 2025;23(3):667\u201383.","journal-title":"Iran"},{"issue":"4","key":"15217_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.34172\/aim.2023.31","volume":"26","author":"A Mirahmadizadeh","year":"2023","unstructured":"Mirahmadizadeh A, Moftakhar L, Dehghani SS, Hassanzadeh J, Dehghani SP, Azarbakhsh H. Mortality rate and years of life lost due to burns in Southern Iran during 2004\u20132019: A Population-Based study. Arch Iran Med. 2023;26(4):205\u201311.","journal-title":"Arch Iran Med"},{"key":"15217_CR17","doi-asserted-by":"crossref","unstructured":"Azarbakhsh H, Sharifi MH, Hassanzadeh J, Dewey RS, Janfada M, Mirahmadizadeh AJIJDDC. Diabetes in southern Iran: a 16-year follow-up of mortality and years of life lost. 2022:1\u20137.","DOI":"10.1007\/s13410-022-01125-9"},{"issue":"9","key":"15217_CR18","doi-asserted-by":"publisher","first-page":"494","DOI":"10.34172\/aim.28159","volume":"27","author":"MH Sharifi","year":"2024","unstructured":"Sharifi MH, Mirahmadizadeh A, Hassanzadeh J, Bazrafshan Drissi H, Azarbakhsh H. Mortality rate and years of life lost due to ischemic heart disease in Southern Iran between 2004 and 2019: A Population-Based study. Arch Iran Med. 2024;27(9):494\u2013500.","journal-title":"Arch Iran Med"},{"issue":"24","key":"15217_CR19","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.21037\/atm-20-7841","volume":"8","author":"R Yang","year":"2020","unstructured":"Yang R, Zhou Y, Wang Y, Du C, Wu Y. Trends in cancer incidence and mortality rates in the united States from 1975 to 2016. Annals Translational Med. 2020;8(24):1671.","journal-title":"Annals Translational Med"},{"issue":"1","key":"15217_CR20","first-page":"47","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4(1):47\u201353.","journal-title":"J Natl Cancer Cent"},{"issue":"2","key":"15217_CR21","doi-asserted-by":"publisher","first-page":"330","DOI":"10.4143\/crt.2022.128","volume":"54","author":"MJ Kang","year":"2022","unstructured":"Kang MJ, Won Y-J, Lee JJ, Jung K-W, Kim H-J, Kong H-J, et al. Cancer statistics in korea: incidence, mortality, survival, and prevalence in 2019. Cancer Res Treatment: Official J Korean Cancer Association. 2022;54(2):330\u201344.","journal-title":"Cancer Res Treatment: Official J Korean Cancer Association"},{"key":"15217_CR22","unstructured":"Etemadi A, Sajadi A, Semnani S, NOURAEI SM, Khademi H, Bahadori M. Cancer registry in Iran: a brief overview. 2008."},{"key":"15217_CR23","doi-asserted-by":"crossref","unstructured":"Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, Maisonneuve P et al. Tobacco smoking and cancer: a meta-analysis. 2008;122(1):155\u201364.","DOI":"10.1002\/ijc.23033"},{"issue":"12","key":"15217_CR24","first-page":"1187","volume":"28","author":"M Ilic","year":"2022","unstructured":"Ilic M, Ilic IJW. Epidemiol Stomach Cancer. 2022;28(12):1187.","journal-title":"Epidemiol Stomach Cancer"},{"key":"15217_CR25","unstructured":"Li H, Terry MB, Antoniou AC, Phillips K-A, Kast K, Mooij TM et al. Alcohol consumption, cigarette smoking, and risk of breast cancer for BRCA1 and BRCA2 mutation carriers: results from the BRCA1 and BRCA2 cohort consortium. 2020;29(2):368\u201378."},{"issue":"1","key":"15217_CR26","doi-asserted-by":"publisher","first-page":"e70399","DOI":"10.1002\/hsr2.70399","volume":"8","author":"M Ghanbari-Jahromi","year":"2025","unstructured":"Ghanbari-Jahromi M, Mobasheri F, Nikbakht HA, Rezaei F. The prevalence and determinants of waterpipe and cigarette smoking among medical sciences students living in dormitories in Southern Iran. Health Sci Rep. 2025;8(1):e70399.","journal-title":"Health Sci Rep"},{"issue":"4","key":"15217_CR27","first-page":"224","volume":"2","author":"F Rezaei","year":"2011","unstructured":"Rezaei F, Nedjat S, Golestan B, Majdzadeh RJI. Comparison of onset age and pattern of male adolescent smoking in two different socioeconomic districts of Tehran. Iran. 2011;2(4):224.","journal-title":"Iran"},{"key":"15217_CR28","doi-asserted-by":"publisher","first-page":"571062","DOI":"10.3389\/fpubh.2020.571062","volume":"8","author":"M-R Sohrabi","year":"2020","unstructured":"Sohrabi M-R, Abbasi-Kangevari M, Kolahi A-A. Current tobacco smoking prevalence among Iranian population: a closer look at the STEPS surveys. Front Public Health. 2020;8:571062.","journal-title":"Front Public Health"},{"issue":"1","key":"15217_CR29","doi-asserted-by":"publisher","first-page":"10272","DOI":"10.1038\/s41598-023-37299-3","volume":"13","author":"M Abbasi-Kangevari","year":"2023","unstructured":"Abbasi-Kangevari M, Ghanbari A, Fattahi N, Malekpour M-R, Masinaei M, Ahmadi N, et al. Tobacco consumption patterns among Iranian adults: a National and sub-national update from the STEPS survey 2021. Sci Rep. 2023;13(1):10272.","journal-title":"Sci Rep"},{"issue":"8","key":"15217_CR30","doi-asserted-by":"publisher","first-page":"e2228544","DOI":"10.1001\/jamanetworkopen.2022.28544","volume":"5","author":"JE Yoo","year":"2022","unstructured":"Yoo JE, Han K, Shin DW, Kim D, Kim B-s, Chun S, et al. Association between changes in alcohol consumption and cancer risk. JAMA Netw Open. 2022;5(8):e2228544\u2013e.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"15217_CR31","doi-asserted-by":"publisher","first-page":"e2326346","DOI":"10.1001\/jamanetworkopen.2023.26346","volume":"6","author":"IM Karaye","year":"2023","unstructured":"Karaye IM, Maleki N, Hassan N, Yunusa I. Trends in alcohol-related deaths by sex in the US, 1999\u20132020. JAMA Netw Open. 2023;6(7):e2326346\u2013e.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"15217_CR32","doi-asserted-by":"publisher","first-page":"e0000107","DOI":"10.1371\/journal.pgph.0000107","volume":"2","author":"N Rezaei","year":"2022","unstructured":"Rezaei N, Ahmadi N, Shams Beyranvand M, Hasan M, Gohari K, Yoosefi M, et al. Alcohol consumption and related disorders in iran: results from the National surveillance of non-communicable diseases\u2019 survey (STEPs) 2016. PLOS Global Public Health. 2022;2(11):e0000107.","journal-title":"PLOS Global Public Health"},{"issue":"1","key":"15217_CR33","doi-asserted-by":"publisher","first-page":"16819","DOI":"10.1038\/s41598-024-66257-w","volume":"14","author":"A Hajebi","year":"2024","unstructured":"Hajebi A, Nasserinejad M, Rezaei N, Azadnajafabad S, Rashidi M-M, Ahmadi N, et al. Alcohol consumption among Iranian population based on the findings of STEPS survey 2021. Sci Rep. 2024;14(1):16819.","journal-title":"Sci Rep"},{"issue":"2","key":"15217_CR34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/cancers15020485","volume":"15","author":"S Pati","year":"2023","unstructured":"Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK. Obesity and cancer: a current overview of epidemiology, pathogenesis, outcomes, and management. Cancers. 2023;15(2):485.","journal-title":"Cancers"},{"key":"15217_CR35","doi-asserted-by":"crossref","unstructured":"Cooper AJ, Gupta SR, Moustafa AF, Chao AM. Sex\/gender differences in obesity prevalence, comorbidities, and treatment. Curr Obes Rep. 2021:1\u20139.","DOI":"10.1007\/s13679-021-00453-x"},{"issue":"4","key":"15217_CR36","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778\u201389.","journal-title":"Int J Cancer"},{"issue":"19","key":"15217_CR37","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1002\/cncr.34390","volume":"128","author":"SS Jackson","year":"2022","unstructured":"Jackson SS, Marks MA, Katki HA, Cook MB, Hyun N, Freedman ND, et al. Sex disparities in the incidence of 21 cancer types: quantification of the contribution of risk factors. Cancer. 2022;128(19):3531\u201340.","journal-title":"Cancer"},{"key":"15217_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fendo.2020.00042","volume":"11","author":"S Djalalinia","year":"2020","unstructured":"Djalalinia S, Saeedi Moghaddam S, Sheidaei A, Rezaei N, Naghibi Iravani SS, Modirian M, et al. Patterns of obesity and overweight in the Iranian population: findings of steps 2016. Front Endocrinol. 2020;11:42.","journal-title":"Front Endocrinol"},{"key":"15217_CR39","doi-asserted-by":"publisher","first-page":"1043894","DOI":"10.3389\/fendo.2022.1043894","volume":"13","author":"S Djalalinia","year":"2022","unstructured":"Djalalinia S, Yoosefi M, Shahin S, Ghasemi E, Rezaei N, Ahmadi N, et al. The levels of BMI and patterns of obesity and overweight during the COVID-19 pandemic: experience from the Iran steps 2021 survey. Front Endocrinol. 2022;13:1043894.","journal-title":"Front Endocrinol"},{"issue":"9859","key":"15217_CR40","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","volume":"380","author":"SS Lim","year":"2012","unstructured":"Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2224\u201360.","journal-title":"Lancet"},{"issue":"8","key":"15217_CR41","doi-asserted-by":"publisher","first-page":"e0330993","DOI":"10.1371\/journal.pone.0330993","volume":"20","author":"SM Mousavi","year":"2025","unstructured":"Mousavi SM, Younesian S, Katebian S, Golestani A, Khanmohammadi S, Khosravi S, et al. Temporal trend in the National and sub-national burden of cancers attributable to risk factors in Iran from 1990 to 2021: findings from the global burden of disease study 2021. PLoS ONE. 2025;20(8):e0330993.","journal-title":"PLoS ONE"},{"key":"15217_CR42","doi-asserted-by":"crossref","unstructured":"Nahvijou AJIJoPH. Disability-Adjusted life years (DALY) for cancers in Iran, 1990 to 2016: review of findings from the global burden of disease study. Iran J Public Health. 2021;50(10):2095.","DOI":"10.18502\/ijph.v50i10.7511"},{"issue":"10","key":"15217_CR43","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/ijc.34659","volume":"153","author":"S Nemati","year":"2023","unstructured":"Nemati S, Mohebbi E, Toorang F, Hadji M, Hosseini B, Saeedi E, et al. Population attributable proportion and number of cancer cases attributed to potentially modifiable risk factors in Iran in 2020. Int J Cancer. 2023;153(10):1758\u201365.","journal-title":"Int J Cancer"},{"key":"15217_CR44","doi-asserted-by":"crossref","unstructured":"Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. The Lancet. 2012;380(9856):1840\u201350.","DOI":"10.1016\/S0140-6736(12)60919-2"},{"issue":"S3","key":"15217_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.7314\/APJCP.2016.17.S3.101","volume":"17","author":"M Mirzaei","year":"2016","unstructured":"Mirzaei M, Mirzadeh M, Mirzaei M. Expected years of life lost due to adult cancer mortality in Yazd (2004\u20132010). Asian Pac J Cancer Prev. 2016;17(S3):101\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"key":"15217_CR46","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s10620-017-4682-z","volume":"62","author":"A Shaukat","year":"2017","unstructured":"Shaukat A, Dostal A, Menk J, Church TR. BMI is a risk factor for colorectal cancer mortality. Dig Dis Sci. 2017;62:2511\u20137.","journal-title":"Dig Dis Sci"},{"issue":"8","key":"15217_CR47","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1158\/1055-9965.EPI-11-0246","volume":"20","author":"MB Cook","year":"2011","unstructured":"Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF. Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev. 2011;20(8):1629\u201337.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"15217_CR48","first-page":"316","volume":"9","author":"Y Veisani","year":"2018","unstructured":"Veisani Y, Khazaei S, Delpisheh A. 5-year survival rates based on the type of leukemia in Iran, a Meta-analysis. Caspian J Intern Med. 2018;9(4):316.","journal-title":"Caspian J Intern Med"},{"issue":"19","key":"15217_CR49","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1002\/cncr.31674","volume":"124","author":"C Bailey","year":"2018","unstructured":"Bailey C, Richardson LC, Allemani C, Bonaventure A, Harewood R, Moore AR, et al. Adult leukemia survival trends in the united States by subtype: A population-based registry study of 370,994 patients diagnosed during 1995\u20102009. Cancer. 2018;124(19):3856\u201367.","journal-title":"Cancer"},{"issue":"4","key":"15217_CR50","first-page":"271","volume":"66","author":"KD Miller","year":"2016","unstructured":"Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA: A cancer. J Clin. 2016;66(4):271\u201389.","journal-title":"J Clin"},{"issue":"10","key":"15217_CR51","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.6004\/jnccn.2019.7305","volume":"17","author":"GL Smith","year":"2019","unstructured":"Smith GL, Lopez-Olivo MA, Advani PG, Ning MS, Geng Y, Giordano SH, et al. Financial burdens of cancer treatment: a systematic review of risk factors and outcomes. J Natl Compr Canc Netw. 2019;17(10):1184\u201392.","journal-title":"J Natl Compr Canc Netw"},{"key":"15217_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-020-01830-4","volume":"18","author":"G Joshy","year":"2020","unstructured":"Joshy G, Thandrayen J, Koczwara B, Butow P, Laidsaar-Powell R, Rankin N, et al. Disability, psychological distress and quality of life in relation to cancer diagnosis and cancer type: population-based Australian study of 22,505 cancer survivors and 244,000 people without cancer. BMC Med. 2020;18:1\u201315.","journal-title":"BMC Med"},{"issue":"3","key":"15217_CR53","first-page":"3","volume":"9","author":"E Mohebbi","year":"2017","unstructured":"Mohebbi E, Nahvijou A, Hadji M, Rashidian H, Seyyedsalehi MS, Nemati S, et al. Iran cancer statistics in 2012 and projection of cancer incidence by 2035. Basic Clin Cancer Res. 2017;9(3):3\u201322.","journal-title":"Basic Clin Cancer Res"},{"key":"15217_CR54","unstructured":"Office for National Statistics. Cancer survival in England: national estimates for patients followed up to 2017. 2019 https:\/\/www.ons.gov.uk\/releases\/ cancersurvivalinenglandadultstageatdiagnosisandchildhoodpatientsfollowedupto2017."},{"issue":"4","key":"15217_CR55","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/00001648-199007000-00012","volume":"1","author":"JW Gardner","year":"1990","unstructured":"Gardner JW, Sanborn JS. Years of potential life lost (YPLL)\u2014what does it measure? Epidemiology. 1990;1(4):322\u20139.","journal-title":"Epidemiology"},{"issue":"10","key":"15217_CR56","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/s41416-023-02422-8","volume":"129","author":"AS Ahmad","year":"2023","unstructured":"Ahmad AS, Offman J, Delon C, North BV, Shelton J, Sasieni PD. Years of life lost due to cancer in the united Kingdom from 1988 to 2017. Br J Cancer. 2023;129(10):1558\u201368.","journal-title":"Br J Cancer"},{"issue":"4","key":"15217_CR57","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/ije\/dyy254","volume":"48","author":"R Martinez","year":"2019","unstructured":"Martinez R, Soliz P, Caixeta R, Ordunez P. Reflection on modern methods: years of life lost due to premature mortality\u2014a versatile and comprehensive measure for monitoring non-communicable disease mortality. Int J Epidemiol. 2019;48(4):1367\u201376.","journal-title":"Int J Epidemiol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15217-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15217-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15217-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:56:01Z","timestamp":1767707761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15217-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15217"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15217-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Shiraz University of Medical Sciences (SUMS) (code: IR.SUMS.REC.1399.772). All aspects of this study were done concerning SUMS\u2019 ethical code. Due to the nature of our study, which was conducted on dead individuals, the university\u2019s ethics committee of Shiraz University of Medical Sciences waived the need for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}